Tamoxifen Unknown Status Phase 2 Trials for Intraocular Melanoma Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00489944Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma